Concert Pharmaceuticals, Inc.
Deuterated EPI-743

Last updated:

Abstract:

This invention relates to novel .alpha.-tocotrienol quinones of Formula I: (I), and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering Vitamin E. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

18 Nov 2016

Issue date:

8 Mar 2022